iBeat
70 South Park Street
San Francisco
California
94107
United States
Tel: 415-496-9682
Website: https://www.ibeat.com/
Email: support@ibeat.com
About iBeat
Located in the heart of San Francisco, iBeat is a technology company empowering people with the freedom to be fearless, take risks, explore, and live longer lives. From a life-saving health records platform to a life-saving Wearable-as-a-Service™, the iBeat team is comprised of several former Practice Fusion veterans dedicated to improving health outcomes and helping pave the future of care delivery.The company is currently building a breakthrough wearable that perpetually monitors and analyzes users’ 24-7 heart activity. In the case of a life-threatening emergency, iBeat will instantly alert the user, their loved ones, and emergency responders in real-time, helping ensure immediate care delivery and potentially saving the user’s life.
YEAR FOUNDED:
2016
LEADERSHIP:
Founder & CEO: Ryan Howard
Co-Founder & Lead Front-End Architect: Larry Stone
Co-Founder & Director of Product: Brian Boarini
CAREER:
Please click here for iBeat's job opportunities.
24 articles about iBeat
-
GeoVax, Inc. And ViaMune To Collaborate On Cancer Immunotherapy Program
11/8/2016
-
GeoVax, Inc. Begins Oncology Immunotherapy Program
12/9/2015
-
Farshad Guirakhoo, Ph.D., Joins GeoVax, Inc. As Senior Vice President, Research And Development
10/20/2015
-
GeoVax, Inc. Reports 2015 Second Quarter Financial Results And Provides Corporate Update
8/4/2015
-
GeoVax, Inc. Receives Grant From NIH For HIV Vaccine Program
7/2/2015
-
GeoVax Labs Inc. DNA/MVA Vaccine Elicits Sustained Antibody Responses to HIV
10/9/2013
-
GeoVax Labs Inc. Reports Financial Results for the Second Quarter and First Half 2013 and Provides Clinical Development Update
8/13/2013
-
GeoVax Labs Inc. Announces Enrollment Completion for Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
1/10/2013
-
GeoVax Labs Inc. to Present at Fifth Annual LD Micro Conference
11/29/2012
-
GeoVax Labs Inc. Reports 2012 Second Quarter Financial Results
8/13/2012
-
GeoVax, Inc. to Attend Biotechnology Industry Organization (BIO) International Convention June 18-21 in Boston
6/11/2012
-
GeoVax, Inc. Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
12/7/2010
-
GeoVax, Inc. Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
11/5/2010
-
GeoVax, Inc. Presents at AIDS Vaccine 2010 Conference in Atlanta
10/1/2010
-
GeoVax, Inc. to Present at HIV/AIDS Vaccine Symposium at New York Academy of Sciences on May 19
5/17/2010
-
GeoVax, Inc. to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
8/26/2009
-
GeoVax, Inc. Update Provided at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2009
2/12/2009
-
GeoVax, Inc. Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
2/25/2008
-
GeoVax, Inc. Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
9/12/2007
-
Dauphin Technology, Inc. Closes Merger With GeoVax, Inc.
10/3/2006